CTI BIOPHARMA CORP - FORM 10-K - EX-21.1 - EXHIBIT 21.1 - March 2, 2017

Attached files

file filename
10-K - 10-K - CTI BIOPHARMA CORPcti10k12312016document.htm
EX-32 - EXHIBIT 32 - CTI BIOPHARMA CORPa2016exhibit32sect906certc.htm
EX-31.2 - EXHIBIT 31.2 - CTI BIOPHARMA CORPa2016exhibit312sect302cert.htm
EX-31.1 - EXHIBIT 31.1 - CTI BIOPHARMA CORPa2016exhibit311sect302cert.htm
EX-23.1 - EXHIBIT 23.1 - CTI BIOPHARMA CORPa2016exhibit231accountingf.htm
EX-12.1 - EXHIBIT 12.1 - CTI BIOPHARMA CORPa2016exhibit121ratioofearn.htm



Exhibit 21.1
Subsidiaries of CTI BioPharma Corp.
Aequus Biopharma, Inc., a Washington corporation; Systems Medicine, LLC, a Delaware limited liability company; and CTI Life Sciences Ltd., a U.K. limited company.
The above paragraph includes all material subsidiaries of CTI BioPharma Corp.



Stock widget

Investing forum

CTI BIOPHARMA CORP Reports